» Articles » PMID: 10543744

Accumulation of 3-ketosteroids Induced by Itraconazole in Azole-resistant Clinical Candida Albicans Isolates

Overview
Specialty Pharmacology
Date 1999 Oct 30
PMID 10543744
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of itraconazole on ergosterol biosynthesis were investigated in a series of 16 matched clinical Candida albicans isolates which had been previously analyzed for mechanisms of resistance to azoles (D. Sanglard, K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille, Antimicrob. Agents Chemother., 39:2378-2386, 1995). Under control conditions, all isolates contained ergosterol as the predominant sterol, except two strains (C48 and C56). In isolates C48 and C56, both less susceptible to azoles than their parent, C43, substantial concentrations (20 to 30%) of 14alpha-methyl-ergosta-8,24(28)-diene-3beta,6alpha-dio l (3, 6-diol) were found. Itraconazole treatment of C43 resulted in a dose-dependent inhibition of ergosterol biosynthesis (50% inhibitory concentration, 2 nM) and accumulation of 3,6-diol (up to 60% of the total sterols) together with eburicol, lanosterol, obtusifoliol, 14alpha-methyl-ergosta-5,7,22,24(28)-tetraene-3betaol, and 14alpha-methyl-fecosterol. In strains C48 and C56, no further increase of 3,6-diol was observed after exposure to itraconazole. Ergosterol synthesis was less sensitive to itraconazole inhibition, as was expected for these azole-resistant isolates which overexpress ATP-binding cassette transporter genes CDR1 and CDR2. In addition to 3,6-diol, substantial amounts of obtusifolione were found after exposure to itraconazole. This toxic 3-ketosteroid was demonstrated previously to accumulate after itraconazole treatment in Cryptococcus neoformans and Histoplasma capsulatum but has not been reported in Candida isolates. Accumulation of obtusifolione correlated with nearly complete growth inhibition in these azole-resistant strains compared to that found in the susceptible parent strain, although the onset of growth inhibition only occurred at higher concentrations of itraconazole. ERG25 and ERG26 are the only genes assigned to the 4-demethylation process, of which the 3-ketoreductase is part. To verify whether mutations in these ERG25 genes contributed to obtusifolione accumulation, their nucleotide sequences were determined in all three related isolates. No mutations in ERG25 alleles of isolates C48 and C56 were found, suggesting that this gene is not involved in obtusifolione accumulation. The molecular basis for the accumulation of this sterol in these two strains remains to be established.

Citing Articles

Pan-azole- and multi-fungicide-resistant is widespread in the United States.

Celia-Sanchez B, Mangum B, Gomez Londono L, Wang C, Shuman B, Brewer M Appl Environ Microbiol. 2024; 90(4):e0178223.

PMID: 38557086 PMC: 11022549. DOI: 10.1128/aem.01782-23.


No evidence of resistance to itraconazole in a prospective real-world trial of dermatomycosis in India.

Handa S, Villasis-Keever A, Shenoy M, Anandan S, Bhrushundi M, Garodia N PLoS One. 2023; 18(2):e0281514.

PMID: 36787305 PMC: 9928099. DOI: 10.1371/journal.pone.0281514.


Impact of TR/L98H, TR/Y121F/T289A and TR Alterations in Azole-Resistant on Sterol Composition and Modifications after In Vitro Exposure to Itraconazole and Voriconazole.

Lavergne R, Albassier M, Hardouin J, Alvarez-Moreno C, Pagniez F, Morio F Microorganisms. 2022; 10(1).

PMID: 35056552 PMC: 8778474. DOI: 10.3390/microorganisms10010104.


High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer.

Datta A, Kim H, McGee L, Johnson A, Talwar S, Marugan J Sci Rep. 2018; 8(1):8161.

PMID: 29802284 PMC: 5970137. DOI: 10.1038/s41598-018-26411-7.


Azole sensitivity in Leptosphaeria pathogens of oilseed rape: the role of lanosterol 14α-demethylase.

Sewell T, Hawkins N, Stotz H, Huang Y, Kelly S, Kelly D Sci Rep. 2017; 7(1):15849.

PMID: 29158527 PMC: 5696480. DOI: 10.1038/s41598-017-15545-9.


References
1.
Joseph-Horne T, Hollomon D, Loeffler R, Kelly S . Cross-resistance to polyene and azole drugs in Cryptococcus neoformans. Antimicrob Agents Chemother. 1995; 39(7):1526-9. PMC: 162775. DOI: 10.1128/AAC.39.7.1526. View

2.
Vanden Bossche H, Dromer F, Improvisi I, Rex J, Sanglard D . Antifungal drug resistance in pathogenic fungi. Med Mycol. 1999; 36 Suppl 1:119-28. View

3.
Vanden Bossche H, Marichal P, Odds F . Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 1994; 2(10):393-400. DOI: 10.1016/0966-842x(94)90618-1. View

4.
Doignon F, Aigle M, Ribereau-Gayon P . Resistance to imidazoles and triazoles in Saccharomyces cerevisiae as a new dominant marker. Plasmid. 1993; 30(3):224-33. DOI: 10.1006/plas.1993.1054. View

5.
Sanglard D, Ischer F, Monod M, Bille J . Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology (Reading). 1997; 143 ( Pt 2):405-416. DOI: 10.1099/00221287-143-2-405. View